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Many viruses utilize host ESCRT proteins for
budding; however, influenza virus budding is thought
to be ESCRT-independent. In this study we have
found a role for the influenza virus M2 proton-selec-
tive ion channel protein in mediating virus budding.
We observed that a highly conserved amphipathic
helix located within the M2 cytoplasmic tail mediates
a cholesterol-dependent alteration in membrane
curvature. The 17 amino acid amphipathic helix is
sufficient for budding into giant unilamellar vesicles,
and mutation of this sequence inhibited budding of
transfected M2 protein in vivo. We show that M2
localizes to the neck of budding virions and that
mutation of theM2 amphipathic helix results in failure
of the virus to undergomembrane scission and virion
release. These data suggest that M2 mediates the
final steps of budding for influenza viruses, bypass-
ing the need for host ESCRT proteins.INTRODUCTION
The budding of enveloped viruses is a complex multi-step
process, the completion of which requires alterations in
membrane curvature and scission at the neck of the budding
virion. Many viruses such as HIV-1, Ebola virus and the para-
myxovirus PIV-5 utilize the host endosomal sorting complex
required for transport (ESCRT) machinery to mediate membrane
scission and virion release (reviewed in Carlton and Martin-
Serrano, 2009; Chen and Lamb, 2008). Matrix proteins from
these and other viruses contain ‘late’ domains, sequences that
bind to proteins of the ESCRT pathway, enabling the virus to
utilize ESCRT proteins that are normally involved in the budding
and release of endosomal vesicles into multi-vesicular bodies.
However, studies indicate that influenza virus may bud indepen-
dently of ESCRT proteins, utilizing an unknown mechanism of
membrane scission and virion release (Bruce et al., 2009; Chen
and Lamb, 2008).
Influenza virus buds from the plasma membrane of infected
cells, producing both 100 nm diameter spherical and902 Cell 142, 902–913, September 17, 2010 ª2010 Elsevier Inc.100 nm 3 2-20 mm filamentous virions. Assembly and budding
is thought to begin with lipid raft-mediated clustering of the
two major viral glycoproteins, the receptor binding/membrane
fusion protein hemagglutinin (HA) and the enzyme neuramini-
dase (NA) (Chen et al., 2007; Leser and Lamb, 2005; Takeda
et al., 2003). Lipid rafts are dynamic plasmamembrane domains,
enriched in sphingolipids and cholesterol, which are thought to
serve as platforms for the concentration of proteins (Brown
and Rose, 1992; Simons and Toomre, 2000). Lipid rafts are
also the sites of budding for several viruses, such as influenza
virus, HIV-1 and Ebola virus (reviewed in Chazal and Gerlier,
2003). Mutations in the HA transmembrane (TM) domain that
eliminate association with lipid rafts, significantly attenuate viral
replication and prevent the formation of filamentous virions
(Chen et al., 2005).
The cytoplasmic tails of HA and NA have been inferred to bind
to the matrix (M1) protein, mediating its incorporation into the
budding virion (Jin et al., 1997). The M1 protein interacts with
the nucleoprotein (NP) and the plasma membrane, facilitating
incorporation of the genome, as a viral ribonucleoprotein
complex (vRNP), into budding virions (Bui et al., 1996; Noton
et al., 2007; Zhang and Lamb, 1996). Mutation of the cytoplasmic
tails of HA and NA reduces the packaging of M1 and produces
defective virions with greatly altered morphology (Barman
et al., 2004; Jin et al., 1997). In conjunction with the HA/NA-M1
interaction, M1 binds to a third viral integral-membrane viral
protein, M2. M2 is a multi-functional protein with proton-selec-
tive ion channel activity. The M1-M2 interaction may enable
the recruitment of M2 to sites of virus budding and mediate the
incorporation of M2 into virions (Chen et al., 2008).
M2 is an essential component of the infectious virion. During
virus entry by endocytosis, endosomal acidification activates
the proton selective ion channel activity of the M2 protein,
causing acidification of the virus interior and leading to dissocia-
tion of M1 from the vRNP (reviewed in Lamb and Pinto, 2005;
Pinto and Lamb, 2006). M2 ion channel activity is inhibited by
the antiviral drug amantadine, which prevents proton flux and
blocks virus uncoating by preventing M1-RNP dissociation
(reviewed in Pinto and Lamb, 2007). The M2 protein contains
97 amino acid residues that assemble into a homotetramer
(Pinto et al., 1997). M2 contains a 24 residue N-terminal extracel-
lular domain, a single TM domain of 19 residues that forms the
pore of the ion channel, and a 54 residue cytoplasmic tail
Figure 1. The M2 Amphipathic Helix
(A) Diagram of structural motifs in the M2 protein. The TM domain/ion channel
pore, CRAC motif and amphipathic helix are indicated. Alanine substituted
residues in the M2(AH-Mut) protein are shown in red.
(B) Helical wheel plot of the M2 amphipathic helix is shown as generated at
http://heliquest.ipmc.cnrs.fr. Hydrophilic residues are shown in black and
hydrophobic resides in gray. The red line separates the two faces of the helix.
See also Figure S1.(Lamb and Pinto, 2005; Zebedee and Lamb, 1988; Pinto et al.,
1997). The first 17 amino acid residues of the M2 protein cyto-
plasmic tail are predicted to form a membrane-parallel, amphi-
pathic helix (Nguyen et al., 2008; Schnell and Chou, 2008; Tian
et al., 2003). In addition to its ion channel activity, recent work
has suggested that the M2 protein may also affect the
morphology of budding virions and may be required for efficient
vRNP packaging, assembly and budding (Chen et al., 2008;
Iwatsuki-Horimoto et al., 2006; McCown and Pekosz, 2005,
2006; Rossman et al., 2010).
Whereas many of the steps required for influenza virus
assembly have been determined, the molecular machinery
needed to complete the budding process has not been eluci-
dated. The available data for influenza virus indicate that the
virus may bud independently of ESCRT proteins, thus the neces-
sary components for membrane scission and virion release are
not known (Bruce et al., 2009; Chen and Lamb, 2008). In this
study we have identified an additional function of the M2 protein
in modifying membrane curvature during virus budding. We
further show that the influenza virus M2 protein mediates
membrane scission, allowing for virion release independent of
the host ESCRT pathway.
RESULTS
Conservation of the M2 Amphipathic Helix
Previous work has suggested that the M2 cytoplasmic tail
may play a role in virus assembly (Chen et al., 2008; Iwatsuki-
Horimoto et al., 2006; McCown and Pekosz, 2005, 2006;
Rossman et al., 2010). Thus, we sought to elucidate the possible
functions of the M2 protein during viral assembly and budding.
Analysis of the M2 protein sequence predicts that the cyto-
plasmic tail contains an amphipathic helix, which has been
confirmed experimentally (Nguyen et al., 2008; Tian et al.,
2003) (Figure 1A). A helical wheel plot of the M2 amphipathic
helix is shown in Figure 1B with the charged and hydrophobic
faces of the helix indicated. Analysis of the amino acid sequence
of M2 across all influenza subtypes for 500 different strains of
influenza A virus, including the recent 2009 H1N1 pandemic
strain and several highly pathogenic H5N1 avian influenza virus
strains, showed significant conservation along the length of the
M2 amphipathic helix (Figure S1 available online), suggesting
that the amphipathic helix has an important role for influenza
virus.
M2 Alters Membrane Curvature
in a Cholesterol-Dependent Manner
Many proteins, including several viral proteins, utilize an amphi-
pathic helix for modifying membrane curvature (reviewed in
Antonny, 2006). To address the role of the M2 amphipathic helix
in virus budding, we first assessed the effect of the amphipathic
helix on membrane curvature. As M2 has been shown to bind
cholesterol (Rossman et al., 2010; Schroeder et al., 2005) and
cholesterol can modify the ability of an amphipathic helix to
induce membrane curvature (de Meyer and Smit, 2009; Egashira
et al., 2002), we also sought to address the possibility of choles-
terol-dependent alterations in membrane curvature by the M2
protein.Wild-type (wt) M2 protein and an amphipathic helix mutant
[M2(AH-Mut)], in which the hydrophobic face of the helix was
altered by changing five bulky hydrophobic residues to alanine
in an attempt to disrupt the function of the helix without disrupt-
ing its a-helicity (Rossman et al., 2010), were purified and recon-
stituted into large unilamellar vesicles (LUVs). Examination of
LUVs reconstituted with wt M2 protein by cryo-electron micros-
copy, or negative staining, showed an alteration in morphology
from control LUVs (Figure 2A and Figure S2A). Wt M2 protein
induced the formation of many ‘flat’ single LUVs, suggesting
that M2 may induce negative membrane curvature (Chernomor-
dik et al., 1995; Russell et al., 2001) in the presence of cholesterol
(Figure 2A and Figure S2A). Additionally, changes in LUV
morphology were found to be independent of M2 ion channel
activity, as incubation with the ion channel blocker amantadine
had no effect (Figures S2B and S2C).
Control LUVs that lacked cholesterol appeared ‘flat’ and
resembled cholesterol-containing LUVs reconstituted in the
presence of wt M2 protein (Figure 2A and Figure S2A). It has
been shown that cholesterol can directly modify membrane
structure, providing an explanation for the different morphology
seen with control LUVs in the presence and absence of choles-
terol (de Meyer and Smit, 2009). When wt M2 was reconstitutedCell 142, 902–913, September 17, 2010 ª2010 Elsevier Inc. 903
Figure 2. M2 Alters Membrane Curvature in a Cholesterol-Dependent Manner
(A) LUVs or cholesterol-free LUVs were reconstituted in the presence or absence of 100 mg purified M2 or M2(AH-Mut) protein and analyzed by cryo-electron
microscopy. NC indicates LUVs containing no cholesterol. Scale bars indicate 100 nm.
(B) LUVs prepared as above, with the addition of a fluorescent membrane dye (shown in green), were dehydrated, electroformed into GUVs and immediately
imaged.
(C) GUVs, prepared as above, with 50 mg purified M2 or 100 mg M2(AH-Mut) protein were resuspended with 0.5 mg/ml of lucifer yellow (shown in blue). LC indi-
cates GUVs containing 0.5 molar % cholesterol.
(D) Two examples of M2-containing GUVs, prepared as above, containing 17 molar % cholesterol. Arrows indicate lucifer yellow containing ILVs.
The scale bars indicate 10 mm. See also Figure S2, Figure S3, and Movie S1 and Movie S2.into LUVs that lacked cholesterol, M2 appeared to induce
positive membrane curvature, and the resulting morphology
resembled control LUVs that contained cholesterol (Figure 2A
and Figure S2A). M2-containing LUVs that lacked cholesterol
showed the formation of many small, aggregated, ‘budding’
LUVs that appear morphologically similar to cholesterol-contain-
ing control LUVs (Figure 2A and Figure S2A). No significant
change in LUV morphology was observed when the vesicles
were reconstituted with M2(AH-Mut) protein in the absence of904 Cell 142, 902–913, September 17, 2010 ª2010 Elsevier Inc.cholesterol, suggesting that the M2 amphipathic helix is neces-
sary for the alteration of membrane curvature in the absence of
cholesterol (Figure 2A and Figure S2A).
Our previous work has shown that influenza virus expressing
M2(AH-Mut) protein is not impaired in ion channel activity,
protein expression or protein localization during virus infection
(Ma et al., 2009; Rossman et al., 2010). However, to control for
possible differences in in vitro membrane incorporation, we
determined the proportion of input wt and M2(AH-Mut) mutant
M2 protein reconstituted into LUVs. Based on an input of 100 mg
of wtM2protein, it was found that 75%was incorporated into the
LUVs. This amount was unaffected by the presence or absence
of cholesterol; however, only 35% of M2(AH-Mut) protein was
incorporated into LUVs, regardless of the presence or absence
of cholesterol. To ensure that the differences in membrane
curvature seen when comparing wt M2 and M2(AH-Mut) were
due to the specific action of the protein, and not due to differ-
ences in protein incorporation, LUVs were made with 50 mg of
wt M2 protein, which gave a final incorporated protein amount
of 31 mg, which is comparable to the 35 mg level obtained with
the M2(AH-Mut) protein. Examination of these LUVs showed
that they retained their induction of positive and negative curva-
ture and appeared indistinguishable from LUVs created with
100 mg of wt M2 protein (Figures S2B and S2C).
M2 Causes Membrane Budding In Vitro
As M2 is capable of altering membrane curvature, we asked if
M2 protein alone is capable of causing membrane budding.
We utilized a system for imaging budding and membrane scis-
sion events within giant unilamellar vesicles (GUVs) that has
been described recently for analyzing the function of proteins
in the ESCRT III complex (Wollert et al., 2009). GUVs were
formed in the presence of 30 or 0.5molar% of cholesterol, incor-
porating purified wt M2 protein or M2(AH-Mut) protein. Low-
cholesterol GUVs containing wt M2 protein exhibited a rapid
budding of the GUV membrane and the formation of many
intra-luminal vesicles (ILVs) (Figure 2B LC+M2, Movie S1). Anal-
ysis of the ILVs showed free movement within the GUV, consis-
tent with completion of membrane scission (Movie S1). Both
inward and outward budding events were observed due to the
random orientation of M2 protein in the lipid bilayer (Figure 2B);
however, outward budding vesicles were seen less frequently
due to rapid diffusion out of the imaging plane following
membrane scission. Low-cholesterol GUVs containing M2(AH-
Mut) protein resembled control GUVs (cf. Figure 2B LC and
LC+M2(AH-Mut), Movie S2), suggesting that the M2 amphi-
pathic helix is essential for M2-mediated membrane budding.
In the presence of high-levels of cholesterol, budding events
were not observed for wt M2 protein (Figure 2B, Cholesterol +
M2). Additionally, control GUVs showed no evidence of budding
when reconstituted in the presence of high or low molar ratios of
cholesterol (Figure 2B GUV + Cholesterol and LC). It is important
to note that the M2-dependent induction of negative curvature
seen in high-cholesterol LUVs (Figure 2A), was not observed in
high-cholesterol GUVs (Figure 2B). It is possible that M2-induc-
tion of negative curvature occurs in GUVs; however, the resulting
changes in morphology may not be resolvable by light micros-
copy and changes in vesicle size may be lost in the normal
background variation of GUV size. Alternatively, the choles-
terol-dependent M2-induction of negative curvature may
depend on the initial degree of membrane curvature, with the
different LUV and GUV radii of curvature affecting themembrane
association and/or curvature induction of the M2 amphipathic
helix.
M2-induced budding was confirmed via the addition of the
small aqueous marker lucifer yellow to the GUV resuspension
buffer. Lucifer yellow fluorescence was observed only withinthe intraluminal vesicles of low-cholesterol GUVs reconstituted
with WT M2 protein (Figure 2C and Figure S3A). Some lucifer
yellow-negative ILVs are observed, however, the M2 protein
begins budding directly after GUV formation has completed
and, thus, some ILVs may complete budding before the addition
of lucifer yellow to the media. Additionally, to confirm that the
lack of budding observed with M2(AH-Mut) seen in Figure 2B
is not due to the lower protein incorporation levels, the GUVs
used in Figure 2C were made from LUVs incorporating 50 mg
of M2 or 100 mg of M2(AH-Mut), resulting in approximately
equal incorporation of these two proteins into the vesicles. No
budding was observed with the M2(AH-Mut) protein, while wt
M2 appeared to bud normally (Figure 2C). As M2 is unlikely
to encounter a lipid environment within the cell that is choles-
terol-free, we reconstituted GUVs containing an intermediate
concentration of cholesterol (17 molar %) with full-length M2
protein. In the presence of 17 molar % cholesterol, M2 caused
membrane budding and the formation of lucifer yellow-contain-
ing ILVs, indicating that M2 is capable of mediating budding in
physiologically-relevant levels of cholesterol (Figure 2D and
Figure S3B).
To determine if the M2 amphipathic helix is sufficient to
mediate GUV budding, a peptide corresponding to the M2
amphipathic helix (M2AH) was synthesized. Addition of the
M2AH peptide to preformed GUVs containing 0.5 molar % of
cholesterol led to rapid budding from the GUV membrane
(Figure 3A, LC + Pep M2AH), resulting in 80.8% (n = 54) of the
GUVs containing at least one ILV. Addition of M2AH peptide to
preformed GUVs containing 30% cholesterol did not cause
budding (Figure 3A cholesterol + Pep M2AH), with only 6.2%
(n = 153) of the GUVs containing an ILV. As electroformed
GUVs show a background level of vesicles containing ILVs
[9.7% (n = 281) of low cholesterol GUVs and 3.7% (n = 42) of
high cholesterol GUVs contain an ILV], we sought to determine
if the ILVs observed in Figure 3A were caused specifically by
peptide-induced membrane budding. Peptide-induced budding
was confirmed via the addition of lucifer yellow to the GUV
resuspension buffer. Addition of lucifer yellow to the GUV
resuspension buffer lead to fluorescence only within low-choles-
terol GUVs that had been treated with the M2AH peptide
[72.5% (n = 54) of peptide treated low cholesterol GUVs con-
tained a lucifer yellow positive ILV, compared to 3.5% (n = 281)
without peptide and 0.5% (n = 153) for peptide-treated high
cholesterol GUVs; Figure S3c], thus confirming that the M2
amphipathic helix is capable of inducing budding and the uptake
of surrounding aqueous media into ILVs (Figure 3B, LC + Pep
M2AH). Interestingly, addition of the M2AH peptide to low-
cholesterol GUVs appeared to cause membrane leakage, in
addition to membrane budding, as shown by the presence of
aqueous lucifer yellow marker within the bulk GUV interior, as
well as within the budded intra-luminal vesicles (Figure 3B). It
is possible that the M2AH peptide possess the ability to form
pores in the membrane bilayer, such as has been noted for
several other amphipathic peptides (Egashira et al., 2002;
Lamaziere et al., 2007; Lee et al., 2008). Pore formation leading
to membrane leakage is seen with the class-A amphipathic
peptide Ac-18A-NH2 (Venkatachalapathi et al., 1993) and pore
formation leading to GUV lysis is seen with the class-LCell 142, 902–913, September 17, 2010 ª2010 Elsevier Inc. 905
Figure 3. The M2 Amphipathic Helix Causes Membrane Budding In Vitro
(A) GUVs electroformed with 30 or 0.5 molar % of cholesterol were treated with 10 mM of the indicated peptide and imaged within 1 hr.
(B) GUVs were prepared and treated as above except that 0.5 mg/ml of lucifer yellow (shown in blue) was added to the resuspension buffer.
(C) GUVs, prepared as above, were treated with M2AH peptide at the indicated concentrations for 1 hr and imaged.
(D) GUVs, prepared as above with the indicated molar % of cholesterol, were treated with 10 mM of M2AH peptide for 1 hr and imaged. 17% cholesterol LY-post
scission indicates 17% cholesterol GUVs to which lucifer yellow was added 1 hr post-treatment with 10 mM of M2AH peptide.
(E) GUVs, prepared as above (with the exception of M2AH-TMR treated samples, for which lucifer yellow was omitted from the resuspension buffer), were treated
with 10 mM of the indicated peptide and imaged within 1 hr. The M2AH-WSN peptide corresponds to the M2 amphipathic helix of A/WSN/33, M2AH-SOIV to
A/California/05/2009, M2AH-Sc to a scrambled sequence of the M2AH peptide, M2AH-TMR to rhodamine-labled M2AH peptide. LC indicates GUVs containing
0.5 molar % of cholesterol.
The scale bars indicate 10 mm. See also Figure S3, Figure S4, and Movie S3.amphipathic peptide melittin (reviewed in Dempsey, 1990)
(Figure S4). However, in the context of the intact M2 protein, it
is likely that the transmembrane domain and the full cytoplasmic906 Cell 142, 902–913, September 17, 2010 ª2010 Elsevier Inc.tail limits the ability of the amphipathic helix to transverse the
bilayer as shown by the absence of membrane leakage during
M2 GUV budding (Figures 2C and 2D).
Titration of the peptide concentration required to induce
budding showed no effect at 5 mM, robust inward budding at
10 mM, a switch to outward budding causing GUV deformation
at 50 mM and robust outward budding leading to lysis of the
GUV at 100 mM (Figure 3C and Movie S3), indicating a dose-
dependent alteration in membrane curvature. The ability of
amphipathic helices to modify membrane curvature and cause
budding is well established (reviewed in Drin and Antonny,
2010) and is shown for the amphipathic peptide RW16 (Lama-
ziere et al., 2007) (Figure S4). Additionally, several amphipathic
helices have been shown to induce both inward and outward
budding depending on the peptide concentration (Lamaziere
et al., 2007), possibly due to concentration-dependent shifts in
peptide orientation in themembrane. A similar activity may occur
with the M2 amphipathic helix peptide, causing the different
forms of budding andmembrane leakage observed in Figure 3C.
Because full-length M2 protein is capable of causing budding
in the presence of intermediate levels of cholesterol, we titrated
the amount of cholesterol that was required to enable GUV
budding by the M2AH peptide. The M2AH peptide induced
GUV budding at cholesterol levels at and below 17 molar %
(Figure 3D), a level that is likely comparable to many regions of
the bulk plasma membrane and is consistent with the choles-
terol-dependence of the full-length M2 protein. Interestingly,
treatment of GUVs, containing 17 molar % cholesterol, with
the M2AH peptide caused budding without membrane leakage
(Figure 3D); further suggesting that the membrane leakage
observed in Figure 3B is not relevant to the budding activity of
the M2 protein. To further confirm the completion of M2-medi-
ated scission, GUVs containing 17 molar % of cholesterol were
treated with the M2AH peptide for 1 hr and then lucifer yellow
was added to the imaging buffer. Lucifer yellow was not found
in the GUV or the ILVs, indicating that the majority of ILVs had
completed scission within the 1 hr treatment and were no longer
assessable to the outside buffer (Figure 3D, 17% Ch LY-Post
Scission).
A synthetic peptide corresponding to the amino acid
sequence of the M2(AH-Mut) amphipathic helix did not cause
GUV budding in the presence of low-levels of cholesterol
(Figures 3A and 3B, LC + Pep M2AH-Mut), nor did a peptide
containing a scrambled version of the M2AH peptide sequence
(Figure 3E, LC + Pep M2AH-Sc). M2AH peptide-induced
budding was further confirmed by the observation that a fluores-
cently-labeled version of the M2AH peptide colocalized with
budded ILVs in low-cholesterol GUVs (Figure 3E, LC + Pep
M2AH-TMR) and with the GUV membrane in the presence of
high-cholesterol levels (Figure 3E, Chol + Pep M2AH-TMR).
Additionally, treatment of low-cholesterol GUVs with peptides
corresponding to the M2 amphipathic helix of the influenza virus
strain A/WSN/33 or of the consensus sequence for the 2009
H1N1 pandemic swine-origin influenza virus (SOIV) strain lead
to a rapid budding of the GUV membrane (Figure 3E, LC + Pep
M2AH-WSN and LC + Pep M2AH-SOIV). The M2AH peptides
exhibited a slight variation in their effects, with the M2AH-WSN
peptide showing reduced membrane leakage and the M2AH-
TMR peptide showing enhanced GUV lysis at the 10 mMconcen-
tration used. However, the consistent induction of membrane
budding in a low-cholesterol environment suggests that M2-mediated membrane budding is a highly conserved function of
the M2 protein.
M2 Causes Budding at Lipid Phase Boundaries
As the M2 protein is capable of inducing budding from single-
phase GUVs, we asked if M2 could mediate budding from
a phase-separated GUV that may better mimic domains within
the plasma membrane (Kaiser et al., 2009). GUVs containing
sphingomyelin, poly-unsaturated phosphocholine and choles-
terol segregate into lipid ordered (Lo) and lipid disordered (Ld)
phases. Incorporation of fluorescent markers allows visualiza-
tion of the two phases (Figure 4A). Addition of a fluorescently-
tagged M2AH peptide to phase-separated GUVs showed that
the amphipathic helix binds to the Ld phase and clusters at the
phase boundary (Figure 4B). Treatment of high-cholesterol
GUVs with the M2 amphipathic helix peptide did not cause
budding and had no observable effect on lipid phase separation
(Figure 4C). However, M2AH peptide-treatment of low-choles-
terol phase-separated GUVs lead to rapid outward budding
beginning with the excision of the Lo phase from the GUV,
in a manner that may be similar to the scission and release of
the lipid-raft rich budding virus from the bulk-phase plasma
membrane, and resulting in numerous, smaller, single-phase
vesicles (Figures 4D and 4E, Figure S5A, and Movie S4). This
suggests that the M2 amphipathic helix may modify the line
tension between lipid phases, subsequently driving budding as
has been previously observed for other proteins that mediate
budding and scission (Allain and Ben Amar, 2006; Liu et al.,
2006; Romer et al., 2010).
To confirm that the full-length M2 protein similarly localizes to
the Ld phase we created plasma membrane spheres (Lingwood
et al., 2008) from M2 and M2 (AH-Mut) expressing cells. By
crosslinking GM1 and using immunofluorescence staining to
detect M2, we observed segregation of the Lo phase and M2,
suggesting that M2 is localized to the Ld phase in living cells
(Figure 4F). Additionally, budding Lo vesicles were seen at the
phase boundary between Lo and M2 with cells expressing wt
M2 but not the mutant M2 (AH-Mut) (Figure 4G and Figures
S5B and S5C), further suggesting that while the M2 amphipathic
helix does not appear to be necessary for the localization of M2
to the Ld phase, the modulation of line tension causing Lo phase
budding requires the wt M2 amphipathic helix.
M2 Causes Membrane Budding In Vivo
As the M2 amphipathic helix is sufficient to induce budding in an
in vitro liposome assay, we assessed the ability of theM2 protein
to induce budding in vivo. Transfection of an M2 expression
plasmid into 293T cells led to the budding and release of M2-
containing vesicles that could be detected by immunoblotting
(Figure 5A) and by electron microscopy (Figure 5B). Wt M2
vesicles appeared aggregated; however, it is unlikely that this
reflects any biologically-relevant activity, as aggregation may
have occurred during concentration of the vesicle-containing
supernatant prior to imaging. The release of M2-containing
vesicles into the culture supernatant was dependent on an intact
amphipathic helix, as expression of M2(AH-Mut) in 293T cells led
to a significant reduction in M2 vesicle release, even when
accounting for the reduced expression level as compared toCell 142, 902–913, September 17, 2010 ª2010 Elsevier Inc. 907
Figure 4. The M2 Amphipathic Helix Causes Membrane Budding at Phase Boundaries
Phase-separated GUVs, electroformed with 20 or 5 molar % of cholesterol and fluorescent markers for the Lo and Ld phase, were treated as indicated and
imaged within 1 hr.
(A) Representative example of phase-separated GUV containing 20 molar % of cholesterol.
(B) Phase-separated GUVs were prepared as above with the Lo marker omitted. GUVs were treated with 10 mM of the M2AH-TMR peptide for 1 hr and imaged.
Arrows indicate clustered M2AH peptide at the phase boundary.
(C and D) (C) Phase-separated GUVs prepared as in Figure 4A containing 20 molar % cholesterol or (D) 5 molar % were resuspended with lucifer yellow, treated
with 10 mM of the M2AH peptide for 1 hr and imaged. Ld phase is shown in red, the Lo phase in green and the aqueous media in blue.
(E) Time lapse images of a GUV from Figure 4D. Note: loss of the Ld signal in later time points is due to the rapid bleaching of the red signal.
(F and G) (F) Plasma membrane spheres were prepared from wt M2 expressing cells or (G) M2(AH-Mut) expressing cells, GM1 was crosslinked to mark the
Lo phase (green) and spheres were stained for M2 (red).
The scale bars indicate 10 mm. Arrows indicate sites of budding. See also Figure S5 and Movie S4.wtM2 (Figure 5).We have shown previously thatM2 exhibits only
minimal cholesterol binding when expressed in the absence of
other viral proteins (Rossman et al., 2010). Thus, M2 expressed
by transient transfection may mediate in vivo budding from
lower-cholesterol regions of the plasma membrane in a manner
that is dependent on the amphipathic helix, similar to the in vitro908 Cell 142, 902–913, September 17, 2010 ª2010 Elsevier Inc.budding of M2 from low-cholesterol GUVs (Figure 2, Figure 3,
and Figure 4).
M2 Localization at the Point of Membrane Scission
For M2 to mediate membrane scission in virus-infected cells, the
M2 protein needs to localize specifically to the neck of the
Figure 5. M2 Causes Membrane Budding In Vivo
(A) 293T cells were transfected with M2 or M2(AH-Mut) expression plasmids
and 24 hr post-transfection the supernatant was harvested, concentrated,
and M2 content was analyzed by Western blot as compared to whole cell
lysates. Values indicate average ± standard deviation of the percentage of
M2 found in the supernatant and calculated from a minimum of three repeats.
M2-low indicates cells transfected with a 4-fold reduction of DNA to provide
comparable M2 expression levels to that of M2(AH-Mut). The vertical line indi-
cates separate blots.
(B) Concentrated supernatant from Figure 5A was analyzed by electron
microscopy. Scale bars indicate 100 nm. The inset is an enlargement of
a 100nm square region of the panel below.
Figure 6. M2 Localizes to the Neck of Budding Virions
MDCK cells were infected with an MOI of 3 pfu/cell of A/Udorn/72 for 18 hr.
(A) Virus-infected cells were fixed and processed for immunofluorescent
detection of HA (shown in green) and M2 (shown in red).
(B) Magnification of images shown in Figure 6A. The scale bars indicate 10 mm.
(C) Virus-infected cells were stained for M2 via immuno-gold labeling and thin
sections were analyzed by electron microscopy.
(D) Magnification of images shown in Figure 6c.
The scale bars indicate 100 nm. Arrows indicate M2 foci at sites of virus
budding. See also Figure S6.budding virion. We have shown previously that M2 is recruited to
lipid rafts and to sites of budding during virus infection (Rossman
et al., 2010). However, whereas M2 can be generally localized to
the base of budding filamentous virions (Figures 6A and 6B), the
specific localization of M2 cannot be resolved via light micros-
copy. Thus, we examined the localization of M2 in virus-infected
cells by immuno-gold labeling and electron microscopy. We
observed that M2 localized to the base of budding filamentous
and spherical virions, and a specific localization at the neck of
budding viruses could be seen for 59.9% (n = 1038) of all immu-nogold-labeled M2 (Figures 6C and 6D), confirming our previous
results showing that the majority of M2 in virally-infected cells is
found at sites of virus budding (Rossman et al., 2010).
M2 localization predominantly but not exclusively to the base
of virions was also observed on viral filaments that had
completed the budding process. Using fluorescent microscopy,
it was observed that in a population of filamentous and spher-
ical virions M2 is concentrated at one end of the filamentous
particles (Figure S6a). Quantification showed that 63% of fila-
ments (n = 300) had a detectable focus of M2, representing the
majority of M2 in the virus. Electron microscopy studies show
that one end of filamentous and a focus on spherical virions
reacts with antibody to M2 and accounts for 79.8% (n = 213)
of all immunogold-labeled M2 found on the virion (Figure S6b).
This concentration of M2 is not seen at the free end of budding
viral filaments, but instead colocalizes with the site of budding
(Figure 6), suggesting thatM2 is incorporated during the comple-
tion of budding, at the trailing end of filamentous virions. This isCell 142, 902–913, September 17, 2010 ª2010 Elsevier Inc. 909
consistent with the role of M2 in mediating membrane scission
and virion release.
Recent results have shown that influenza virus budding is
dependent on the expression of Rab11 (Bruce et al., 2010).
Rab11 is known to function in endosomal budding aswell as traf-
ficking of proteins to the apical plasma membrane, thus knock-
down of Rab11 could have a direct role in membrane scission or
could affect the transport of influenza virus proteins, such asM2.
siRNA knock-down of Rab11a/b led to greater than 85%
knock-down in Rab11a protein levels (Figure S7A) and a statisti-
cally-significant 40% reduction in the levels of M2 found on the
cell surface, while the levels of HA increased 2-fold (Figures
S7B andS7C). This difference cannot be attributed to expression
differences as the levels of HA and M2 were comparable in
control and Rab11 knock-down cells (Figure S7D). Thus, while
a further affect of Rab11 cannot be ruled out, it is likely that
Rab11 has an essential role in the transport of M2 to the apical
membrane and not a direct role in membrane scission.
Mutation of theM2Amphipathic Helix BlocksMembrane
Scission
Although the data shown here indicate that M2 localizes to the
neck of budding viruses and is capable of mediating budding
and membrane scission in vitro as well as in vivo, it does not
distinguish between an additive role of the M2 protein in virus
budding and a necessary role for the M2 protein in mediating
membrane scission. To determine whether the M2 amphipathic
helix is required for virus budding and membrane scission, we
examined the budding of wt and M2 mutant influenza viruses
by thin section electron microscopy. Whereas in wt virus-
infected cells the budding of filamentous and spherical virions
could be observed at the cell surface (Figure 7A), cells infected
with M2(AH-Mut) virus showed the presence of many virions
in the process of budding; however, the scission and release
of these virions appeared to be impaired (Figures 7A and 7B).
These mutant virions on the surface of M2(AH-Mut) virus-
infected cells exhibited the classical ‘‘beads on a string’’
morphology found in viruses with late domain mutations that
are unable to recruit host ESCRT proteins, and so fail to undergo
membrane scission (Figure 7B) (Yuan et al., 2000). It is important
to note that, though the membrane neck connecting each of the
attached virions was not always visible, this is most likely due to
its presence out of the plane of sectioning. Immuno-gold labeling
of M2(AH-Mut) incompletely-budded virions showed that
56.5% (n = 929) of all gold particles localized to M2 foci at the
base of the budding M2(AH-Mut) virions and also at the constric-
tions between incompletely budded virions (Figure 7C). This
suggests that M2 is incorporated into the virion as budding
nears completion and that mutation of the M2 amphipathic helix
leads to incorporation of M2 at the membrane proximal end of
each particle; however, M2 is unable to complete membrane
scission, resulting in a string of attached particles. The ‘beads
on a string’ morphology is also found during infection with a virus
that does not produce the M2 protein (DM2; Figures 7A and 7D),
confirming an earlier observation (McCown and Pekosz, 2006).
The failed-scission morphology of both M2(AH-Mut) and DM2
viruses (Figures 7B and 7D), coupled with previous results
showing that these viruses have a significant growth defect910 Cell 142, 902–913, September 17, 2010 ª2010 Elsevier Inc.and are impaired in viral particle release (Cheung et al., 2005;
Jackson and Lamb, 2008; Rossman et al., 2010), suggests that
M2 plays a necessary role in mediating membrane scission
and is required for the efficient release of budding virions.
DISCUSSION
Although many steps in the assembly of influenza virus have
been proposed, the final pinching off of a budding virion
(membrane scission) lacks for a mechanistic explanation. In
this study we identify a crucial role for the influenza virus M2
protein in virus budding. We observe that M2 is capable of
altering membrane curvature, causing membrane budding and
scission in a reduced-cholesterol environment (Figure 2). During
virus assembly and budding, M2 localizes to the neck of budding
virions (Figure 6) where it is required for membrane scission and
the release of budding virions (Figure 7).
Our previous work showed that expression of HA, NA or M2
causes budding in a VLP system, however, expression of both
HA and M2 increased the efficiency of VLP release compared
to each protein alone (Chen et al., 2007). During virus infection,
mutation or deletion of HA eliminates the production of infectious
virus, but does not significantly alter the numbers of viral parti-
cles that bud from the cell (Chen et al., 2005; Pattnaik et al.,
1986). In contrast, mutation or deletion of the M2 protein impairs
both infectivity as well as viral particle release, for multiple
different influenza virus strains (Chen et al., 2008; Cheung
et al., 2005; Iwatsuki-Horimoto et al., 2006; McCown and
Pekosz, 2005, 2006; Rossman et al., 2010). In the absence of
M2, budding virions still form, however, membrane scission
and virion release never occurs (Figures 7B and 7D). This
suggests that HA may be able to initiate the budding event, but
that assembly of other viral proteins may prevent membrane
scission until the recruitment of M2.
Following the HA-mediated initiation of virus budding, M1may
bridgeHA andM2, allowing for the recruitment ofM2 to the, lipid-
raft enriched, sites of virus budding (Chen et al., 2008; Rossman
et al., 2010). M2 in this cholesterol-rich environment would be
unable to induce membrane scission (Figure 2) and may induce
negative membrane curvature instead (Figure 2A). This block in
scission may stabilize the site of virus budding long enough to
allow for recruitment and assembly of the full complement of viral
proteins. Virion assembly may eventually deplete the local pool
of raft-associated HA, placing M2 at the boundary between the
lipid ordered phase of the budding virus and the lipid disordered
phase of the bulk plasma membrane (Rossman et al., 2010).
Acting at the phase boundary, insertion of the M2 amphipathic
helix into the Ld phase may alter the line tension between the
lipid phases (Figure 4). M2-mediated modifications of line
tensionmay provide the driving force for alterations inmembrane
curvature, as has been previously suggested for other line-
tension altering proteins (Allain and Ben Amar, 2006; Liu et al.,
2006; Romer et al., 2010). Alternatively, theM2 amphipathic helix
may only be able to insert into low-cholesterol membranes due
to rigidifying effects of cholesterol. Deep insertion of the amphi-
pathic helix into the membrane may directly induce lipid packing
defects, causing alterations in membrane curvature without the
need for line tension-derived energy. Alteration of membrane
Figure 7. The M2 Amphipathic Helix is Necessary for Membrane Scission and Virion Release
MDCK cells were infected with an MOI of 3 pfu/cell of (A) A/Udorn/72, (A–C) A/Udorn/72 M2(AH-Mut) or (D) A/Udorn/72-DM2 for 18 hr and thin sections were
analyzed by electron microscopy. M2 was detected via immunogold labeling in (C). Arrows indicate foci of M2 at points of failed membrane scission. The scale
bars indicate 100 nm.curvature at the neck of the budding virus may be sufficient to
cause membrane scission and the release of the budding virus
(Figure 2, Figure 3, Figure 6, and Figure 7). Mutation of the M2
amphipathic helix or alteration of M2 localization though disrup-
tion of M1 binding prevents membrane scission and the release
of the budding virion, explaining the growth defect observed in
both mutant viruses (Chen et al., 2008; McCown and Pekosz,
2006; Rossman et al., 2010).
Our results show a mechanism for influenza virus budding,
that of a virus-encoded scission machine. Future investigation
will determine if other enveloped viruses whose budding is
thought to be ESCRT-independent (reviewed in Chen and
Lamb, 2008) also encode their own ESCRT-substitutes, capable
of mediating membrane scission and virus release. Our datashow that the M2 amphipathic helix is necessary and sufficient
to mediate membrane scission, and suggest that M2 may func-
tion as a virus-encoded ESCRT substitute, responsible for medi-
ating the budding of influenza virions. Thus, we conclude thatM2
is amultifunctional protein that, in addition to its proton-selective
ion channel activity, has an essential role in virus budding.
EXPERIMENTAL PROCEDURES
Cell, Viruses, and Reagents
Madin-Darby canine kidney (MDCK) cells, M2-MDCK cells, 293T cells, viral
stock propagation and viral infections were as previously described (Chen
et al., 2008). M2 AH-Mut (previously called M2-Helix) and DM2 recombinant
viruses have been previously described (Rossman et al., 2010; Jackson and
Lamb, 2008). Antibodies used were: aHA (NR3118, BEI, Manassas, VA) andCell 142, 902–913, September 17, 2010 ª2010 Elsevier Inc. 911
aM2 (ectodomain mAb 14C2; (Zebedee and Lamb, 1988). Peptides were
synthesized by GenScript (Piscataway, NJ). Additional detail is included as
supplemental information.
Immunofluorescence Microscopy
MDCK cells grown on glass coverslips were infected as indicated, fixed and
stained for HA and M2. Virus supernatant was stained following spotting on
a glass coverslip. For Rab11 knock-down, A549 cells were transfected
with control siRNA or siRNAs targeting Rab11a and Rab11b, infected as indi-
cated and stained for HA and M2. Fluorescent intensity was quantified for
50–100 cells and averaged. Images were collected on a LSM5 Pascal (Zeiss,
Thornwood, NY) confocal microscope.
Electron Microscopy
LUVs were treated as indicated and stained with phosphotungstic acid before
imaging. For cryo-electron microscopy, LUVs were imbedded in vitreous ice
using an FEI Vitrobot (Hillsboro, Or) and imaged using a Gatan (Pleasanton,
CA) cryo-holder. For analysis of virus-infected cells, MDCK cells were treated
as indicated and subjected to preembedding aM2 immunogold labeling
followed by thin section examination as previously described (Leser et al.,
1996). Samples were imaged on a JEOL 1230 (Tokyo, Japan) electron micro-
scope.
Protein Purification
M2 and M2(AH-Mut) were expressed using the Bac-N-Blue baculovirus
expression system (Invitrogen) and purified as previously described (Tosteson
et al., 1994).
Large Unilamellar Vesicles
LUVs were prepared by extrusion from a 4:1:2 molar ratio of POPC:POPG:
Cholesterol (Avanti Polar Lipids, Alabaster, AL) or a 4:1 molar ratio of POPC:
POPG using purified wt M2 or M2 mutant protein where indicated.
Giant Unilamellar Vesicles
GUVs were electroformed using LUV lipid ratios with 0.5 mol % of TopFluor-
Cholesterol (Avanti) added for visualization. Phase separated GUVs were
electroformed at 60C using a 2:2:1 or 10:10:1 molar ratio of DOPC:SM:Cho-
lesterol, incorporating 0.5 mol% of TopFluor-Cholesterol and Rho-PE (Avanti).
GUVs containing M2 protein were prepared through dehydration of M2-con-
taining LUVs as previously described (Girard et al., 2004; Streicher et al., 2009).
Plasma Membrane Spheres
Plasma membrane spheres were prepared as previously described (Keller
et al., 2009; Lingwood et al., 2008), transfected with M2 or M2(AH-Mut)-
pCAGGS and incubated in PMS buffer for 12 hr. For visualization PMSs
were incubated with labeled CTxB, stained for M2 and imaged at 37C.
Budding Assay
293T cells were transfected with M2 or M2(AH-Mut)-pCAGGS. 24 hr post-
transfection supernatant was collected and concentrated. Supernatant and
cell lysates were analyzed by SDS-PAGE and immunoblotting as previously
described (Chen et al., 2008).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and four movies and can be found with this article online at doi:
10.1016/j.cell.2010.08.029.
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